• Model of Viral Lifecycle Could Help in Finding a Cure for Hepatitis B
    A new technique for studying the lifecycle of the hepatitis B virus could help researchers develop a cure for the disease. In a paper published today in the journal Proceedings of the National Academy of Sciences, Sangeeta Bhatia of MIT and Charles Rice of Rockefeller ...More
    3 weeks ago Posted in News
  • Study Predicts Hepatitis C Will Become a Rare Disease in 22 Years
    Effective new drugs and screening would make hepatitis C a rare disease by 2036, according to a computer simulation conducted by the University of Texas MD Anderson Cancer Center and the University of Pittsburgh Graduate School of Public Health. The results of the ...More
    3 weeks ago Posted in News
  • Hepatitis C Virus Genotype 1 is Most Prevalent Worldwide
    In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journal of the American Association for the Study of Liver ...More
    4 weeks ago Posted in News
  • New Oral Drug Regimens Cure Hardest-to-Treat Hepatitis C
    Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies published in The ...More
    4 weeks ago Posted in News
  • 1 in 3,000 Blood Donors in England Infected with Hepatitis E
    The first systematic analysis of hepatitis E virus (HEV) transmission by blood components indicates that about 1 in 3,000 donors in England have HEV in their plasma. The findings, published in The Lancet, suggest that around 1,200 HEV-containing blood components (e.g., red ...More
    4 weeks ago Posted in News
  • WHO Welcomes Global Momentum on Viral Hepatitis
    On World Hepatitis Day, July 28, the World Health Organization (WHO) welcomes new progress in tackling one of the world’s most serious diseases. Viral hepatitis – a group of infectious diseases known as hepatitis A, B, C, D, and E – affects millions of ...More
    4 weeks ago Posted in News
  • Hepatitis C Cured in Co-Infected HIV Patients
    A multicenter team of researchers report that in a phase III clinical trial, a combination drug therapy cures chronic hepatitis C in the majority of patients co-infected with both HIV and hepatitis C. "In many settings, hepatitis C is now a leading cause of death among HIV ...More
    July 21, 2014 Posted in News
  • Major Gaps in Hepatitis C Care Identified as New Drugs and Screening Efforts Emerge
    A new meta-analysis published online in PLOS ONE by infectious disease and epidemiology specialists from the Perelman School of Medicine at the University of Pennsylvania highlights significant gaps in hepatitis C care that will prove useful as the U.S. health care system ...More
    July 2, 2014 Posted in News
  • Penn Immunologist to Co-Direct $12 Million Grant to Study Hepatitis
    John Wherry, PhD, an associate professor of microbiology in the Perelman School of Medicine at the University of Pennsylvania, and colleagues from Massachusetts General Hospital (MGH) are co-directing a $12 million grant to study immune responses in people who have been ...More
    June 30, 2014 Posted in News
« Previous12345678910115152Next »